Heart Valve Operations in Solid Organ Recipients: An 18-Year Single-Center Experience
| Autor: | Holger Klose, Charles A. Yankah, R. Baretti, Roland Hetzer, Michele Musci, Rudolf Meyer, Yuguo Weng |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Adolescent medicine.medical_treatment Kidney Function Tests Blood Urea Nitrogen Aortic valve replacement Mitral valve Internal medicine Humans Medicine Heart valve Survival rate Aged Transplantation Tricuspid valve business.industry Mitral valve replacement Organ Transplantation Middle Aged Creatine medicine.disease Cardiac surgery Surgery Survival Rate medicine.anatomical_structure Heart Valve Prosthesis cardiovascular system Cardiology Female business |
| Zdroj: | Transplantation. 84:592-597 |
| ISSN: | 0041-1337 |
| DOI: | 10.1097/01.tp.0000279005.85046.a6 |
| Popis: | Background We retrospectively analyzed the outcome of heart valve operations in solid organ recipients, who were referred for operation to our institution. Methods Over an 18-year period, 23 heart (group 1) and 16 renal (group 2) transplant recipients in New York Heart Association (NYHA) classes III and IV underwent valve operation. The mean interval from the time of transplantation to cardiac surgery was 77.9 months with a mean follow-up time of 34.6 months in group 1 and 87.2 months with a mean follow-up time of 39.2 months in group 2. Results Group 1 underwent tricuspid valve replacement (n=12), tricuspid valve reconstruction (n=7), aortic valve replacement (AVR, n=3), and mitral valve replacement (MVR, n=1). In group 2, mechanical valve replacement was performed in 14 patients (9 AVR, 3 MVR, 2 AVR and MVR) and tricuspid or mitral valve reconstruction in two patients. There was no operative death. During hospitalization, multiorgan failure due to sepsis was the main cause of mortality (2 in both groups). In the mean follow-up period of 41.2 months, there were four late non-cardiac-related deaths in group 1. Currently 29 surviving transplant recipients (16 heart, 69.6% and 13 renal, 81.3%) are in NYHA classes I and II. Conclusion In heart and renal recipients, valve operations can be performed effectively and safely with acceptable mortality, low cardiac morbidity, and excellent clinical results, although infection is the most serious complication. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|